Generics BulletinIn a financial third quarter of ups and downs, India’s Torrent Pharmaceuticals managed to offset currency headwinds in Brazil and a downturn in its US business thanks to double-digit growth in India a
Generics BulletinBoehringer Ingelheim is cashing in on its diabetes franchise related to sodium glucose co-transporter-2 (SGLT-2) inhibitor empagliflozin in India ahead of the local patent expiry for the molecule in M
ScripScrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. Kaken Obtains Aadi’s Fyarro, Comm
Generics BulletinOver 50 drugs were listed in the Indian Central Drugs Standard Control Organisation’s latest ‘not of standard quality’ reports, flagging potential quality issues in widely used medicinal products in t